Biovigensp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2013-03-08
Share capital
30,000.00 PLN
Registered address
Wrzosowa 39, 98-220 Tymienice, Poland
Electronic delivery address
AE:PL-44567-41835-CVBIV-20

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 85 days late).

  • 202506/07/2026
  • 202404/07/2025
  • 202324/06/2024
  • 202210/07/2023
  • 202108/10/2022
  • 202015/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Wholesale of pharmaceutical goods493 / 1,141
Top 43%
Division · Wholesale trade6,459 / 19,982
Top 32%
Voivodeship · Łódzkie2,861 / 15,300
Top 19%
Country · Poland53,550 / 297,873
Top 18%

Results vs industry

Revenue
This companyUSD 2.47mMedianUSD 1.07mAverageUSD 22.38m
Net profit
This companyUSD 421.69kMedianUSD 37.89kAverageUSD 879.28k
Operating costs
This companyUSD 1.88mMedianUSD 929.75kAverageUSD 21.06m
Assets
This companyUSD 1.21mMedianUSD 609.81kAverageUSD 11.84m

Public procurement

76 tenders recorded as contractor: 30 national ($1,942,428) and 46 EU ($6,089,509).

SubjectAmount
Supply of reagents, calibrators, control and consumable materials for testing antiarrhythmic drugs and MPA and MPAG in serum/plasma using the QTRAP4500 by LC-MS/MS; probes; kits for quantitative mutation testing; disposable kits for the Spectra Optia cell separator; and reagents for diagnosing haemochromatosis by real-time PCR using the existing Roche LightCycler instrument
$18,671
Supply of reagents, consumables and other items covered by the contract.
$12,723
Lease of analyzers and devices together with the purchase of consumables, and purchase of individual consumables for Zakład Genetyki
$18,395

Authorized Representatives

Wiesława Kopaczyńska – President of the Management Board
Michał Owczarek – Attorney-in-fact (sole)

Manner of representation

If the management board is a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
Magdalena Eliza Lis Owczarekage 50
120$3,241.4940%
Michał Owczarekage 46
180$4,862.2460%

Michał Owczarek and Magdalena Eliza Lis Owczarek hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2013-03-21.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
OMET Medicalsp. z o.o.
Cytogen - Polskasp. z o.o.
Goldfarmexsp. z o.o.
Orthoactivesp. z o.o.
Tecnobody Polskasp. z o.o.
CanpolandS.A.
Geneco Groupsp. z o.o.
Novaova Sosnowski Wadowskisp. k.
Endolink PharmaS.A.
Novaovasp. z o.o.

Change history

DateEvent
2025-10-28Address change
2013-03-08Entered in the register

FAQ

Last updated: 2026-07-09